Many studies have reported that the ERK–NF-κB axis plays a critical role in the cell proliferation/survival pathway of various malignant tumors such as osteosarcoma [61], breast cancer [62], pancreatic cancer [63], oral cancer [64] and hepatocellular carcinoma [65]. Here, NFKB1 is linked to cancer.